A 2025 meta-analysis (Harrer et al.) finds psychotherapy has large effects for phobias, PTSD, OCD, and social/generalized anxiety, moderate for depression, and small but positive effects for psychosis and suicidal ideation. It also reports similar effectiveness in non‑Western and low‑/middle‑income countries compared with Western, wealthy settings.
— Quantified, cross‑disorder effect sizes and cross‑region parity can guide resource allocation, set realistic expectations, and counter claims that therapy is primarily a Western intervention.
Josh Zlatkus
2026.04.15
72% relevant
This article argues that psychotherapies often package persuasive stories rather than literally true mechanisms yet still produce benefit; that claim connects to the existing idea that therapeutic effectiveness is heterogeneous and mechanism‑dependent — the author cites Stephen Grosz and contrasts psychoanalytic explanations with evolutionary or situational accounts, which is directly relevant to debates over when and why therapy works and therefore which disorders or contexts it helps.
Josh Zlatkus
2026.04.15
65% relevant
The article questions standard therapeutic explanations (transference, unconscious processing, insight) and offers lower‑level social/evolutionary accounts (relationship formation, suggestion, confirmation bias) — a reframing that connects to the existing idea that therapy is not a one‑size‑fits‑all intervention and that mechanisms and effectiveness differ across conditions.
Jake Currie
2026.04.10
70% relevant
The DARC‑NESS model argues that nightmares persist because of specific maintaining mechanisms (appraisal, conditioned arousal, low 'nightmare efficacy') and therefore responds to different, targeted interventions—this maps directly onto the existing idea that treatment effectiveness depends on matching therapy to the disorder's mechanisms; the article cites Lisa Cromer and a Frontiers in Sleep paper as the source of the model.
Jake Currie
2026.04.08
60% relevant
The article supplies mechanistic evidence that synaptic overactivity is an early driver in Sanfilippo syndrome, implying that timing and mechanism‑matched therapies (e.g., early synaptic modulators, gene or cell therapies) will determine treatment success—directly connecting to the claim that therapeutic effectiveness depends on disease biology and disorder class.
EditorDavid
2026.03.28
75% relevant
The piece reports growing clinical evidence that high‑dose psilocybin is effective for major depression and mentions potential for PTSD and addiction, illustrating the uneven, disorder-specific evidence base that shapes where and how psychedelic therapies are adopted (cites Dr. Albert Garcia‑Romeu and researchers' hypotheses about mechanisms).
Jake Currie
2026.03.20
60% relevant
The lung‑cancer immunotherapy study shows that baseline thymic health predicts immunotherapy success (≈37% lower progression risk, 44% lower death risk), illustrating how patient biology beyond tumor genomics — here immune‑system aging — changes treatment effectiveness.
Joanna Steinhardt
2026.03.17
70% relevant
The article interrogates claims that ibogaine (and other psychedelics) are transformational cures by reporting a vivid personal retreat experience paired with lingering uncertainty about long‑term effects; that ties to the broader idea that therapeutic outcomes differ across conditions and contexts and cautions against overgeneralizing anecdotal 'cures'.
The Living Fossils
2026.03.11
65% relevant
The piece questions the simple neurotransmitter model of mental illness and the clear efficacy of antidepressants, aligning with the existing idea that therapeutic benefit is heterogeneous across disorders and treatments rather than uniform.
Steven Gussman
2026.03.03
60% relevant
The article treats exposure therapy as an empirically grounded intervention and offers a mechanistic account (Bayesian updating) that helps explain why CBT/exposure shows large effects for some disorders — directly linking to the idea that therapy outcomes differ by diagnostic category.
Abigail Marsh
2026.03.03
70% relevant
Abigail Marsh’s interview distinguishes psychopathy/low empathy from other antisocial conditions and discusses the neural and behavioral features that make empathy‑based interventions less effective — directly supporting the claim that not all mental‑health conditions respond the same way to therapy and that treatment policy should be disorder‑specific.
Kristen French
2026.01.16
60% relevant
Both items concern the clinical impact of treatments for mental illness; the Nautilus story reports a pharmacological route that could complement or alter psychotherapeutic approaches and triage (e.g., which disorders favor drug vs therapy), linking directly to the article’s emphasis on differential clinical benefit and safety across diagnoses.
Kristen French
2026.01.13
78% relevant
Nautilus summarizes a Lancet Psychiatry qualitative study that reframes delusions as lived, embodied phenomena; that connects to the existing idea that different disorders respond differently to psychotherapy and implies different therapeutic targets and expectations for psychosis care (actor: Lancet Psychiatry authors; claim: delusions arise from altered embodied experience, not just false beliefs).
msmash
2026.01.12
75% relevant
Both items are high‑quality meta‑analytic syntheses about mental‑health treatments; this Cochrane review complements and extends the earlier finding that treatment effect sizes differ by disorder by showing that, for depression specifically, exercise produces effect sizes comparable to pharmacological and psychological interventions (biological mechanisms such as BDNF noted in the article).
Carolyn D. Gorman
2026.01.08
76% relevant
The article leans on Bonanno’s work and the broader literature showing heterogeneous psychotherapy outcomes across disorders and that most people follow a resilience trajectory after acute traumatic events; this directly connects to the existing idea that clinical benefit is disorder‑specific and that blanket, post‑event therapy programs are not empirically justified.
Kristen French
2026.01.07
48% relevant
Both items concern differential clinical evidence across conditions and how robust data should drive care and resource allocation; Streicher’s survey (3,800 respondents; 86 reported peri‑orgasmic phenomena) is an empirical input that could guide whether specialized diagnostic categories or therapeutic approaches are warranted, analogous to how the cited meta‑analysis parsed psychotherapy effectiveness by disorder.
Devin Reese
2026.01.02
45% relevant
Both pieces touch clinical heterogeneity in mental states: the Nautilus article reports a measurable neurophysiological state ('mind blanking') that the authors link to anxiety and ADHD, which could affect how and when psychotherapy shows benefit or how clinicians assess symptom phenomenology—connecting neuroscientific measurement to the existing idea that therapeutic effects differ by disorder and that better measurement should guide allocation of care.
Kristen French
2025.12.30
55% relevant
Both items sit in the same public‑health/psychology space: the Nautilus article provides new empirical detail about parental burnout as a distinct clinical/social problem and how it degrades emotional presence, which bears on conclusions about where psychotherapy, screening, and service delivery will be most effective and which disorders or social conditions warrant targeted intervention.
Bob Grant
2025.12.04
72% relevant
The Nautilus article reports an empirical mechanism (failure to downshift cognitive state) that helps explain why generic interventions may fail for insomnia and points toward disorder‑specific treatments (circadian interventions, targeted CBT‑I, neuromodulation) — directly connecting to the existing idea that therapeutic effectiveness differs across conditions and must be evidence‑matched.
Yascha Mounk
2025.12.02
78% relevant
Marsh’s discussion of psychopathy as a distinct personality disorder with boldness, meanness, and disinhibition maps onto the existing idea that therapeutic effectiveness differs across diagnoses: psychopathic traits predict particular treatment challenges and require different intervention targets than, say, anxiety or depression.
Steve Stewart-Williams
2025.10.01
100% relevant
The article lists Hedges’ g values (e.g., phobias g=1.25; PTSD g=1.18; psychotic disorders g=0.32) and notes no efficacy gap between Western and non‑Western contexts.